专利检索 ap:("GlaxoSmithKline Intellectual Property (No. 2) Limited") AND inv:"LAFRANCE, III, Louis Vincent" 第 1 页

1.

发明授权
ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS 有权

公开(公告)号：EP3452483B1

公开(公告)日：2020-04-01

申请号：EP17723766.6

申请日：2017-05-01

申请人： GlaxoSmithKline Intellectual Property (No. 2) Limited

发明人： KNIGHT, Steven David , LAFRANCE, III, Louis Vincent , TIAN, Xinrong

IPC分类号： C07D495/04

2.

发明公开
ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS 审中-公开

公开(公告)号：EP3452483A1

公开(公告)日：2019-03-13

申请号：EP17723766.6

申请日：2017-05-01

申请人： GlaxoSmithKline Intellectual Property (No. 2) Limited

发明人： KNIGHT, Steven David , LAFRANCE, III, Louis Vincent , TIAN, Xinrong

IPC分类号： C07D495/04

摘要： This invention relates to novel compounds according to Formula (I) which are inhibitors of Enhancer of Zeste Homolog 2 (EZH2), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of cancers.